
Abby Carr
Articles
-
Aug 8, 2023 |
dailysignal.com | Abby Carr
Must Reads Big TechBorder CrisisChinaCritical Race TheoryElection IntegrityLettersPodcasts “They call it dope for a reason,” anti-drug campaigns used to say.
-
Aug 7, 2023 |
msn.com | Paul Larkin |Abby Carr
Xylazine—a tranquilizer approved as a sedative for veterinary medical use but not for any use in humans—is currently worsening the opioid crisis. Known on the street as “tranq,” xylazine has become a common additive to substances such as fentanyl, heroin, and cocaine, whether taken orally, by smoking or snorting it, or by injecting it.
-
Aug 6, 2023 |
msn.com | Paul Larkin |Abby Carr
Xylazine—a tranquilizer approved as a sedative for veterinary medical use but not for any use in humans—is currently worsening the opioid crisis. Known on the street as “tranq,” xylazine has become a common additive to substances like fentanyl, heroin, and cocaine, whether taken orally, by smoking or snorting it, or by injecting it.
-
Aug 6, 2023 |
19fortyfive.com | Paul Larkin |Abby Carr
Xylazine—a tranquilizer approved as a sedative for veterinary medical use but not for any use in humans—is currently worsening the opioid crisis. Known on the street as “tranq,” xylazine has become a common additive to substances like fentanyl, heroin, and cocaine, whether taken orally, by smoking or snorting it, or by injecting it.
-
Aug 4, 2023 |
dailysignal.com | Abby Carr
Must Reads Big Tech Border Crisis China Critical Race Theory Election Integrity Letters Podcasts Xylazine—a tranquilizer approved as a sedative for veterinary medical use but not for any use in humans—is currently worsening the opioid crisis. Known on the street as “tranq,” xylazine has become a common additive to substances like fentanyl, heroin, and cocaine, whether taken orally, by smoking or snorting it, or by injecting it. It creates a double whammy, enhancing the psychotropic effects of...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →